Carapinha J - Search Results

1

Introduction to the new column of the BRICS Medicines Alliance.

Carapinha J, Provin MP, Pinheiro R, Ziganshina L, Khaziakhmetova VN, Chandy SJ, Ishaq GM, Sun J, Zhang L, Suleman F, Pharasi B; BRICS Medicines Alliance. Carapinha J, et al. J Evid Based Med. 2013 Feb;6(1):2-3. doi: 10.1111/jebm.12019. J Evid Based Med. 2013. PMID: 23557522 No abstract available.

2

Ebola Virus Epidemic in West Africa: Global Health Economic Challenges, Lessons Learned, and Policy Recommendations.

Elmahdawy M, Elsisi GH, Carapinha J, Lamorde M, Habib A, Agyie-Baffour P, Soualmi R, Ragab S, Udezi AW, Usifoh C, Usifoh S. Elmahdawy M, et al. Among authors: carapinha j. Value Health Reg Issues. 2017 Sep;13:67-70. doi: 10.1016/j.vhri.2017.08.003. Epub 2017 Sep 13. Value Health Reg Issues. 2017. PMID: 29073992 Free article.

3

A budget impact analysis of budesonide/formoterol in patients with mild asthma in Egypt.

Elsisi GH, Carapinha J, Amin W, Thabet E, Elafify S, Amin M, Hatem A. Elsisi GH, et al. Among authors: carapinha j. J Med Econ. 2019 Oct;22(10):1047-1054. doi: 10.1080/13696998.2019.1642899. Epub 2019 Aug 1. J Med Econ. 2019. PMID: 31298593 Free article.

4

A budget impact analysis of lenalidomide in multiple myeloma Egyptian patients.

Elsisi GH, Carapinha JL, Afify R, Elmoty MA, Khalaf M. Elsisi GH, et al. Among authors: carapinha jl. J Med Econ. 2020 Oct;23(10):1168-1175. doi: 10.1080/13696998.2020.1796288. Epub 2020 Jul 27. J Med Econ. 2020. PMID: 32669063 Free article.

5

Budget impact analysis for dapagliflozin in type 2 diabetes in Egypt.

Elsisi GH, Anwar MM, Khattab M, Elebrashy I, Wafa A, Elhadad H, Awad M, Carapinha JL. Elsisi GH, et al. Among authors: carapinha jl. J Med Econ. 2020 Aug;23(8):908-914. doi: 10.1080/13696998.2020.1764571. Epub 2020 May 28. J Med Econ. 2020. PMID: 32364032 Free article.

6

A budget impact analysis of substituting sitagliptin with liraglutide in type 2 diabetes from a private health insurance perspective in Egypt.

Elsisi GH, Afify A, Abgad A, Zakaria I, Nasif N, Ibrahim HN, Raafat N, Carapinha JL. Elsisi GH, et al. Among authors: carapinha jl. Cost Eff Resour Alloc. 2022 Jan 15;20(1):1. doi: 10.1186/s12962-021-00335-y. Cost Eff Resour Alloc. 2022. PMID: 35033094 Free PMC article.

7

Cost-effectiveness of six months versus 1-year adjuvant trastuzumab in HER2 positive early breast cancer in Egypt.

Elsisi GH, Nada Y, Rashad N, Carapinha J, Noor AO, Almasri DM, Zaidy MA, Foad A, Khaled H. Elsisi GH, et al. Among authors: carapinha j. J Med Econ. 2020 Jun;23(6):575-580. doi: 10.1080/13696998.2020.1724682. Epub 2020 Feb 24. J Med Econ. 2020. PMID: 32011199 Free article.

8

A comparative review of the pharmacoeconomic guidelines in South Africa.

Carapinha JL. Carapinha JL. J Med Econ. 2017 Jan;20(1):37-44. doi: 10.1080/13696998.2016.1223679. Epub 2016 Aug 26. J Med Econ. 2017. PMID: 27564849 Free article.

9

Health insurance systems in five Sub-Saharan African countries: medicine benefits and data for decision making.

Carapinha JL, Ross-Degnan D, Desta AT, Wagner AK. Carapinha JL, et al. Health Policy. 2011 Mar;99(3):193-202. doi: 10.1016/j.healthpol.2010.11.009. Epub 2010 Dec 16. Health Policy. 2011. PMID: 21167619

10

Cost-effectiveness of sorafenib versus best supportive care in advanced hepatocellular carcinoma in Egypt.

Hamdy Elsisi G, Nada Y, Rashad N, Carapinha J. Hamdy Elsisi G, et al. Among authors: carapinha j. J Med Econ. 2019 Feb;22(2):163-168. doi: 10.1080/13696998.2018.1552432. Epub 2018 Dec 13. J Med Econ. 2019. PMID: 30479174 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

19 results

Search Page